Research ArticleArticle
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance
Daniel B. Horton, Karen B. Onel, Timothy Beukelman and Sarah Ringold
The Journal of Rheumatology February 2017, jrheum.161078; DOI: https://doi.org/10.3899/jrheum.161078
Daniel B. Horton
From the Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey; Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York; Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama; Seattle Children’s Hospital and Research Institute, University of Washington School of Medicine, Seattle, Washington, USA. Funded by Rutgers Biomedical and Health Sciences and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR070286). D.B. Horton, MD, MSCE, Assistant Professor of Pediatrics, Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences; K.B. Onel, MD, Chief, Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College; T. Beukelman, MD, MSCE, Associate Professor, Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham; S. Ringold, MD, MS, Assistant Professor, Seattle Children’s Hospital, University of Washington School of Medicine. Address correspondence to Dr. D.B. Horton, 112 Paterson St., New Brunswick, New Jersey 08901, USA. E-mail: daniel.horton@rutgers.edu. Accepted for publication December 8, 2016.
Karen B. Onel
From the Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey; Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York; Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama; Seattle Children’s Hospital and Research Institute, University of Washington School of Medicine, Seattle, Washington, USA. Funded by Rutgers Biomedical and Health Sciences and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR070286). D.B. Horton, MD, MSCE, Assistant Professor of Pediatrics, Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences; K.B. Onel, MD, Chief, Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College; T. Beukelman, MD, MSCE, Associate Professor, Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham; S. Ringold, MD, MS, Assistant Professor, Seattle Children’s Hospital, University of Washington School of Medicine. Address correspondence to Dr. D.B. Horton, 112 Paterson St., New Brunswick, New Jersey 08901, USA. E-mail: daniel.horton@rutgers.edu. Accepted for publication December 8, 2016.
Timothy Beukelman
From the Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey; Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York; Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama; Seattle Children’s Hospital and Research Institute, University of Washington School of Medicine, Seattle, Washington, USA. Funded by Rutgers Biomedical and Health Sciences and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR070286). D.B. Horton, MD, MSCE, Assistant Professor of Pediatrics, Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences; K.B. Onel, MD, Chief, Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College; T. Beukelman, MD, MSCE, Associate Professor, Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham; S. Ringold, MD, MS, Assistant Professor, Seattle Children’s Hospital, University of Washington School of Medicine. Address correspondence to Dr. D.B. Horton, 112 Paterson St., New Brunswick, New Jersey 08901, USA. E-mail: daniel.horton@rutgers.edu. Accepted for publication December 8, 2016.
Sarah Ringold
From the Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey; Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York; Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama; Seattle Children’s Hospital and Research Institute, University of Washington School of Medicine, Seattle, Washington, USA. Funded by Rutgers Biomedical and Health Sciences and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR070286). D.B. Horton, MD, MSCE, Assistant Professor of Pediatrics, Division of Pediatric Rheumatology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, Institute for Health, Health Care Policy and Aging Research, Rutgers Biomedical and Health Sciences; K.B. Onel, MD, Chief, Division of Pediatric Rheumatology, Department of Pediatrics, Hospital for Special Surgery, Weill Cornell Medical College; T. Beukelman, MD, MSCE, Associate Professor, Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham; S. Ringold, MD, MS, Assistant Professor, Seattle Children’s Hospital, University of Washington School of Medicine. Address correspondence to Dr. D.B. Horton, 112 Paterson St., New Brunswick, New Jersey 08901, USA. E-mail: daniel.horton@rutgers.edu. Accepted for publication December 8, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance
Daniel B. Horton, Karen B. Onel, Timothy Beukelman, Sarah Ringold
The Journal of Rheumatology Feb 2017, jrheum.161078; DOI: 10.3899/jrheum.161078
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance
Daniel B. Horton, Karen B. Onel, Timothy Beukelman, Sarah Ringold
The Journal of Rheumatology Feb 2017, jrheum.161078; DOI: 10.3899/jrheum.161078